SUDARSHAN PHARMA INDUSTRIES LI (SUDARSHAN.BO)

INR 27.0

(-0.95%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020
Total Assets 2.83 Billion 2.32 Billion 1.37 Billion 992.6 Million 583.77 Million
Total Current Assets 2.41 Billion 1.98 Billion 1.29 Billion 876.43 Million 468.82 Million
Cash And Short Term Investments 16.43 Million 178.04 Million 44.72 Million 23.87 Million 14.48 Million
Cash and Cash Equivalents 1.43 Million 178.04 Million 44.72 Million 23.87 Million 14.48 Million
Short Term Investments 15 Million - - - -
Net Receivables 1.22 Billion 930.01 Million 737.77 Million 606.43 Million 276.69 Million
Inventory 857.41 Million 745.67 Million 468.69 Million 239.64 Million 173.77 Million
Other Current Assets 316.41 Million 132.48 Million 44.6 Million 6.48 Million 3.86 Million
Total Non-Current Assets 415.53 Million 338.86 Million 79.41 Million 116.16 Million 114.95 Million
Net PPE 224.09 Million 190.02 Million 68.84 Million 59.8 Million 52.83 Million
Good Will And Intangible Assets 43.59 Million 8.96 Million 1.19 Million 2.32 Million 3.51 Million
Good Will 43.59 Million - - - -
Intangible Assets 6.15 Million 8.96 Million 1.19 Million 2.32 Million 3.51 Million
Long-Term Investments 123.41 Million 123.41 Million 22 Thousand 22 Thousand 22 Thousand
Tax Assets 6.15 Million 300 Thousand -1000.00 - -
Other Non Current Assets 18.28 Million 16.15 Million 9.36 Million 54.01 Million 58.58 Million
Other Assets - 1.00 - - -
Total Liabilities 1.71 Billion 1.31 Billion 1.07 Billion 767.04 Million 385.42 Million
Total Current Liabilities 1.6 Billion 1.18 Billion 1.02 Billion 712.21 Million 343.38 Million
Account Payables 567.15 Million 918.89 Million 737.51 Million 442.17 Million 164.36 Million
Tax Payables - 6.39 Million 3.26 Million - -
Short Term Debt 943.46 Million 213.15 Million 256.52 Million 244.5 Million 166.99 Million
Deferred Revenue 1.00 13.47 Million 4.31 Million - -
Other Current Liabilities 97.62 Million 39.25 Million 27.89 Million 25.54 Million 12.03 Million
Total Non Current Liabilities 105.94 Million 130.57 Million 51.21 Million 54.82 Million 42.03 Million
Long-Term Debt 104.91 Million 127.88 Million 49.39 Million 53.2 Million 41.09 Million
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 853 Thousand 593.99 Thousand 416.99 Thousand 250.99 Thousand 142.99 Thousand
Other Liabilities - 1.00 1.00 1.00 -
Total Equity 1.11 Billion 1 Billion 297.75 Million 225.55 Million 198.35 Million
Stock Holders Equity 1.11 Billion 1 Billion 297.75 Million 225.07 Million 198.35 Million
Common Stock 240.65 Million 240.65 Million 97.49 Million 95.47 Million 95.47 Million
Retained Earnings 298.3 Million 190.97 Million 120.6 Million 68.12 Million 41.4 Million
Accumulated other comprehensive income - 818.76 Million 177.14 Million 156.94 Million 156.94 Million
Common Stock Equity 1.11 Billion 1 Billion 297.75 Million 225.07 Million 198.35 Million
Capital Lease Obligation - - - - -
Total Investments 138.41 Million 123.41 Million 22 Thousand 22 Thousand 22 Thousand
Total Debt 1.04 Billion 341.03 Million 305.92 Million 297.7 Million 208.09 Million
Net Debt 1.04 Billion 162.99 Million 261.19 Million 273.83 Million 193.6 Million

Balance Sheet Charts

Created with Highcharts 11.1.0Value in INRYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity202020212022202301B2B3B
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio20202021202220231.21.31.41.51.61.70200 M400 M600 M800 M1 000 M